Patents by Inventor Urban Scheuring

Urban Scheuring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy comprising diaryl ureas for treating diseases
    Publication number: 20090306020
    Abstract: The present invention relates to pharmaceutical compositions and combinations for treating cancer, comprising a diaryl urea compound and an PI3K/AKT signaling pathway inhibitor. Useful combinations include e.g. BAY-43-9006 as a diaryl urea compound.
    Type: Application
    Filed: May 13, 2006
    Publication date: December 10, 2009
    Applicant: Bayer Healthcare AG
    Inventors: Urban Scheuring, Ingo Bernard, Claus Garbe, Birgit Schittek, Friedegund Meier
  • COMPOSITIONS AND METHODS FOR INHIBITING HIV INFECTIONS BY INHIBITING LEREPO4 AND GLIPR
    Publication number: 20090233985
    Abstract: The present invention relates to inhibitor molecules of LEREPO4 or GliPR or respective functional homologues thereof including siRNAs, shRNAs, antisense RNAs, antisense DNA and dominant negative proteinaceous mutants of LEREPO4 or functional homologues thereof. The present invention also relates to pharmaceutical compositions and methods for preventing and/or inhibiting HIV infections by inhibiting the function of LEREPO4 or GliPR or respective functional ho mo logues thereof in vivo. Furthermore, the present invention relates to methods of treating, preventing or diagnosing AIDS and/or HIV infections in an individual. Moreover, the present invention relates to diagnostic methods to determine the susceptibility of HIV strains and isolates for such LEREPO4 or GliPR directed treatment.
    Type: Application
    Filed: July 11, 2007
    Publication date: September 17, 2009
    Inventor: Urban Scheuring
  • Combination therapy comprising a diaryl urea compound and a p13, akt kinase or mtor inhibitors (rapamycins) for cancer treatment
    Publication number: 20090192127
    Abstract: The present invention relates to pharmaceutical compositions and combinations for treating cancer, comprising a diaryl urea compound e.g. 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and an PI3K/AKT signaling pathway inhibitor The PI3K/AKI signaling pathway inhibitor comprises PI3 inhibitors {like celecoxilo, viridins, wortmannins}, AKT kinase inhibitors {like perifosine, triciribine} and mTOR inhibitors {like the rapamycins temsirolimus and evorolimus}.
    Type: Application
    Filed: May 13, 2006
    Publication date: July 30, 2009
    Applicant: Bayer Healthcare AG
    Inventors: Urban Scheuring, Ingo Bernard